Back to Search
Start Over
Eisai's sNDA Filing for ARICEPT(R) in the Treatment of Severe Alzheimer's Disease Not Accepted by FDA Due to Formatting Deficiencies
- Source :
- PR Newswire. October 28, 2005
- Publication Year :
- 2005
-
Abstract
- TOKYO, and TEANECK, N.J., Oct. 27 /PRNewswire-FirstCall/ -- . Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO Haruo Naito) and Eisai Inc. (Headquarters: Teaneck, NJ, Chairman and CEO Hajime Shimizu) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.138026666